{"entity":{"type":"insider","cik":"0001291769","url":"/insider/0001291769","json_url":"/insider/0001291769.json","name":"Warren Howland Shaw","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":55,"n_filings":15,"first":"2005-10-11","last":"2006-04-26","span_basis":"filed_date"},"name_variants":[{"name":"Warren Howland Shaw","source":"filing","n_filings":15,"first_seen":"2005-10-11","last_seen":"2006-04-26"}],"transactions":[{"id":5306578,"accession":"0001209191-06-025464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-025464","line_url":"/filing/0001209191-06-025464#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.2375,"price_display":"5.24","price_state":"stated","total_value":41900.0,"total_display":"41,900.00","total_whole":"41,900","shares_owned_after":224600.0,"shares_owned_after_display":"224,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-04-25","filed_date":"2006-04-26","scope":"insider"},{"id":5582084,"accession":"0001209191-06-020331","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-020331","line_url":"/filing/0001209191-06-020331","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.022625,"price_display":"5.02","price_state":"stated","total_value":40181.0,"total_display":"40,181.00","total_whole":"40,181","shares_owned_after":215244.0,"shares_owned_after_display":"215,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-28","filed_date":"2006-03-28","scope":"insider","n_lines":4},{"id":3891622,"accession":"0001209191-06-017648","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-017648","line_url":"/filing/0001209191-06-017648#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.568,"price_display":"5.57","price_state":"stated","total_value":44544.0,"total_display":"44,544.00","total_whole":"44,544","shares_owned_after":219244.0,"shares_owned_after_display":"219,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-14","filed_date":"2006-03-14","scope":"insider"},{"id":2766688,"accession":"0001209191-06-013711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-013711","line_url":"/filing/0001209191-06-013711","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.421,"price_display":"5.42","price_state":"stated","total_value":43368.0,"total_display":"43,368.00","total_whole":"43,368","shares_owned_after":231244.0,"shares_owned_after_display":"231,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-28","filed_date":"2006-02-28","scope":"insider","n_lines":2},{"id":5556863,"accession":"0001209191-06-010478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-010478","line_url":"/filing/0001209191-06-010478#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":5.254,"price_display":"5.25","price_state":"stated","total_value":42032.0,"total_display":"42,032.00","total_whole":"42,032","shares_owned_after":235244.0,"shares_owned_after_display":"235,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-24","filed_date":"2006-02-14","scope":"insider"},{"id":3574214,"accession":"0001209191-06-004821","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-06-004821","line_url":"/filing/0001209191-06-004821","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":6.2912125,"price_display":"6.29","price_state":"stated","total_value":50329.7,"total_display":"50,329.70","total_whole":"50,330","shares_owned_after":247544.0,"shares_owned_after_display":"247,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-24","filed_date":"2006-01-24","scope":"insider","n_lines":4},{"id":3504543,"accession":"0001209191-06-002940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-002940","line_url":"/filing/0001209191-06-002940","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":6.73345,"price_display":"6.73","price_state":"stated","total_value":53867.6,"total_display":"53,867.60","total_whole":"53,868","shares_owned_after":254844.0,"shares_owned_after_display":"254,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-01-10","filed_date":"2006-01-10","scope":"insider","n_lines":2},{"id":1562421,"accession":"0001209191-05-065668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-065668","line_url":"/filing/0001209191-05-065668","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":6.68617875,"price_display":"6.69","price_state":"stated","total_value":53489.43,"total_display":"53,489.43","total_whole":"53,489","shares_owned_after":261144.0,"shares_owned_after_display":"261,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-27","filed_date":"2005-12-28","scope":"insider","n_lines":2},{"id":1572560,"accession":"0001209191-05-063085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-063085","line_url":"/filing/0001209191-05-063085#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":6.745,"price_display":"6.74","price_state":"stated","total_value":53960.0,"total_display":"53,960.00","total_whole":"53,960","shares_owned_after":267244.0,"shares_owned_after_display":"267,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-12-13","filed_date":"2005-12-13","scope":"insider"},{"id":1355225,"accession":"0001209191-05-059155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-059155","line_url":"/filing/0001209191-05-059155","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":6.554875,"price_display":"6.55","price_state":"stated","total_value":52439.0,"total_display":"52,439.00","total_whole":"52,439","shares_owned_after":277844.0,"shares_owned_after_display":"277,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-22","filed_date":"2005-11-22","scope":"insider","n_lines":3},{"id":1355197,"accession":"0001209191-05-056409","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-05-056409","line_url":"/filing/0001209191-05-056409","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":7.55125,"price_display":"7.55","price_state":"stated","total_value":60410.0,"total_display":"60,410.00","total_whole":"60,410","shares_owned_after":286444.0,"shares_owned_after_display":"286,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-08","filed_date":"2005-11-09","scope":"insider","n_lines":5},{"id":1262544,"accession":"0001209191-05-053741","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-05-053741","line_url":"/filing/0001209191-05-053741","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":8.657875,"price_display":"8.66","price_state":"stated","total_value":69263.0,"total_display":"69,263.00","total_whole":"69,263","shares_owned_after":294344.0,"shares_owned_after_display":"294,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-25","filed_date":"2005-10-26","scope":"insider","n_lines":10},{"id":9260736,"accession":"0001209191-05-053211","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-05-053211","line_url":"/filing/0001209191-05-053211","is_derivative":false,"issuer_cik":"0001291769","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001291769","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":8.50025,"price_display":"8.50","price_state":"stated","total_value":68002.0,"total_display":"68,002.00","total_whole":"68,002","shares_owned_after":299944.0,"shares_owned_after_display":"299,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-21","scope":"insider","n_lines":9},{"id":1529518,"accession":"0001209191-05-051985","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-05-051985","line_url":"/filing/0001209191-05-051985#line-9","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":8.49,"price_display":"8.49","price_state":"stated","total_value":17829.0,"total_display":"17,829.00","total_whole":"17,829","shares_owned_after":304144.0,"shares_owned_after_display":"304,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-11","scope":"insider"},{"id":1529517,"accession":"0001209191-05-051985","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-05-051985","line_url":"/filing/0001209191-05-051985#line-8","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":8.49,"price_display":"8.49","price_state":"stated","total_value":12735.0,"total_display":"12,735.00","total_whole":"12,735","shares_owned_after":302644.0,"shares_owned_after_display":"302,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-11","scope":"insider"},{"id":1529516,"accession":"0001209191-05-051985","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-05-051985","line_url":"/filing/0001209191-05-051985#line-7","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":8.49,"price_display":"8.49","price_state":"stated","total_value":10188.0,"total_display":"10,188.00","total_whole":"10,188","shares_owned_after":301444.0,"shares_owned_after_display":"301,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-11","scope":"insider"},{"id":1529515,"accession":"0001209191-05-051985","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-05-051985","line_url":"/filing/0001209191-05-051985#line-6","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":9350.0,"total_display":"9,350.00","total_whole":"9,350","shares_owned_after":300344.0,"shares_owned_after_display":"300,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-11","scope":"insider"},{"id":1529514,"accession":"0001209191-05-051985","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-05-051985","line_url":"/filing/0001209191-05-051985#line-5","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CRITICAL THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001291769","owner_name":"Warren Howland Shaw","owner_display_name":"Warren Howland Shaw","owner_url":"/insider/0001291769","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":4285.0,"total_display":"4,285.00","total_whole":"4,285","shares_owned_after":299844.0,"shares_owned_after_display":"299,844","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-10-11","filed_date":"2005-10-11","scope":"insider"}],"collapsed":true,"next_cursor":"2005-10-11|1529514","ledger_fault":false,"count":{"value":55,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":55},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CRITICAL THERAPEUTICS INC","url":"/issuer/0001145404","role":"Director","n_filings":15,"first_seen":"2005-10-11","last_seen":"2006-04-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001291769","retrieved_at":"2026-08-25T09:09:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}